From basic research to clinical practice: considerations for treatment drugs for silicosis
R Li, H Kang, S Chen - International Journal of Molecular Sciences, 2023 - mdpi.com
Silicosis, characterized by irreversible pulmonary fibrosis, remains a major global public
health problem. Nowadays, cumulative studies are focusing on elucidating the pathogenesis …
health problem. Nowadays, cumulative studies are focusing on elucidating the pathogenesis …
Idiopathic pulmonary fibrosis therapy development: a clinical pharmacology perspective
TH Mai, LW Han, JC Hsu… - … in Respiratory Disease, 2023 - journals.sagepub.com
Drug development for idiopathic pulmonary fibrosis (IPF) has been challenging due to
poorly understood disease etiology, unpredictable disease progression, highly …
poorly understood disease etiology, unpredictable disease progression, highly …
A new model of acute exacerbation of experimental pulmonary fibrosis in mice
CH Yegen, L Haine, K Da Costa Ferreira, D Marchant… - Cells, 2022 - mdpi.com
Rationale: idiopathic pulmonary fibrosis (IPF) is the most severe form of fibrosing interstitial
lung disease, characterized by progressive respiratory failure leading to death. IPF's natural …
lung disease, characterized by progressive respiratory failure leading to death. IPF's natural …
The sialidase NEU3 promotes pulmonary fibrosis in mice
D Pilling, K Sahlberg, TR Karhadkar, W Chen… - Respiratory …, 2022 - Springer
Background Sialic acid is often the distal sugar on glycoconjugates, and sialidases are
enzymes that remove this sugar. In fibrotic lesions in human and mouse lungs, there is …
enzymes that remove this sugar. In fibrotic lesions in human and mouse lungs, there is …
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
B Ozaltin, R Chapman, MQU Arfeen, N Fitzpatick… - Respiratory …, 2024 - Springer
Background Our study examined whether prevalent and incident comorbidities are
increased in idiopathic pulmonary fibrosis (IPF) patients when compared to matched chronic …
increased in idiopathic pulmonary fibrosis (IPF) patients when compared to matched chronic …
Prognosis and Survival in Idiopathic Pulmonary Fibrosis in the Era of Antifibrotic Therapy in Italy: Evidence from a Longitudinal Population Study Based on Healthcare …
M Iommi, A Faragalli, M Bonifazi, F Mei… - International Journal of …, 2022 - mdpi.com
The aim was to evaluate the determinants of acute exacerbation (AE) and death in new
cases of idiopathic pulmonary fibrosis (IPF) using administrative databases in the Marche …
cases of idiopathic pulmonary fibrosis (IPF) using administrative databases in the Marche …
Prognostic value of tripartite motif (TRIM) family gene signature from bronchoalveolar lavage cells in idiopathic pulmonary fibrosis
M Zhou, J Ouyang, G Zhang, X Zhu - BMC Pulmonary Medicine, 2022 - Springer
Background Tripartite motif (TRIM) family genes get involved in the pathogenesis and
development of various biological processes; however, the prognostic value of TRIM genes …
development of various biological processes; however, the prognostic value of TRIM genes …
Inhibiting a mRNA motif binding protein that mediates TGF-β1 upregulation of translation attenuates pulmonary fibrosis in mice
In human lung cells, the profibrotic cytokine TGF-β1 increases sialidase 3 (NEU3) protein by
increasing NEU3 translation without increasing levels of NEU3 mRNA. To elucidate how …
increasing NEU3 translation without increasing levels of NEU3 mRNA. To elucidate how …
[PDF][PDF] High-resolution CT patterns in the assessment of disease progression, outcome, and risk factors for complications of transbronchial lung cryobiopsy in interstitial …
M Mononen - 2023 - dspace.uef.fi
Interstitial lung diseases (ILDs) include a large number of diseases affecting the peripheral
lung. Patterns of inflammation and fibrosis are created mostly in the interstitium between the …
lung. Patterns of inflammation and fibrosis are created mostly in the interstitium between the …
[PDF][PDF] The sialidase NEU3 promotes pulmonary fibrosis in mice
Background Sialic acid is often the distal sugar on glycoconjugates, and sialidases are
enzymes that remove this sugar. In brotic lesions in human and mouse lungs, there is …
enzymes that remove this sugar. In brotic lesions in human and mouse lungs, there is …